ZEB1 directly inhibits GPX4 transcription contributing to ROS accumulation in breast cancer cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10549-021-06301-9.pdf
Reference44 articles.
1. Krebs AM et al (2017) The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol 19:518–529. https://doi.org/10.1038/ncb3513
2. Brabletz S, Brabletz T (2010) The ZEB/miR-200 feedback loop–a motor of cellular plasticity in development and cancer? EMBO Rep 11:670–677. https://doi.org/10.1038/embor.2010.117
3. Jiang Y, Wang D, Ren H, Shi Y, Gao Y (2018) Oncogenic HBXIP enhances ZEB1 through Sp1 to accelerate breast cancer growth. Thorac Cancer 9:1664–1670. https://doi.org/10.1111/1759-7714.12878
4. Feng S et al (2019) Multi-dimensional roles of ketone bodies in cancer biology: opportunities for cancer therapy. Pharmacol Res 150:104500. https://doi.org/10.1016/j.phrs.2019.104500
5. Poprac P et al (2017) Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol Sci 38:592–607. https://doi.org/10.1016/j.tips.2017.04.005
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. GPX4 transcriptionally promotes liver cancer metastasis via GRHL3/PTEN/PI3K/AKT axis;Translational Research;2024-09
2. Curcumol promotes ferroptosis of colon cancer by targeting the ubiquitination and degradation of GPX4;Journal of Traditional and Complementary Medicine;2024-08
3. miR-141-3p attenuates RSL3-induced ferroptosis and intestinal epithelial-mesenchymal transition via directly inhabits ZEB1 in intestinal Behçet’s syndrome;Clinical Rheumatology;2024-05-20
4. Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma;Frontiers in Pharmacology;2024-04-22
5. Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer’s disease;Neural Regeneration Research;2024-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3